Ten years of change in French people's perceptions and opinions regarding drugs (1999-2008)
Tendances n° 71, OFDT, 6 p.
The third edition (1999, 2002, 2008) of the Enquête sur les représentations, opinions et perceptions sur les psychotropes (Survey on Representations, Opinions, and Perceptions Regarding Psychoactive Drugs, EROPP)/survey which provides information about representations, opinions and perceptions French people have with regard to psychoactive substances helped review changes in the French population’s understanding and opinions related to drugs and the main public policies developed in the last few years. In late 2008 (the survey was conducted from 27 October to 25 December 2008), 2,300 randomly selected people aged 15 to 75 were called at home and invited to express their opinions through a 20-minute questionnaire. The main themes examined by this OFDT survey were perceptions of the dangers linked to the use of psychoactive substances, fears aroused by such substances and opinions on current public policy measures taken or which should be taken in this regard. To avoid making the questionnaire too burdensome, opinions were only asked on five of the most frequently used or well-known substances: two legal substances (alcohol and tobacco) and three illegal drugs (cannabis, cocaine and heroin).
Jean-Michel Costes, Olivier Le Nézet, Stanislas Spilka, Cécile Laffiteau
Download the PDF file (238 Ko)
Drugs in Europe
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2019 EMCDDA European Drug Report.
Country drug reports 2019
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.